from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0359/-

LFCtreatmentdescriptionclass of inhibitor

-0.050

Amikacinug/mL Amikacintranslation

0.355

Cap5-10ug/mL Capreomycintranslation

0.592

Rox10-50 ug/mL Roxithromycintranslation

-0.740

SM2-5 ug/mL Streptomycintranslation

0.350

Tet5-10 ug/mL Tetracyclinetranslation

-0.027

Rif0.2-5ug/mL Rifampicintranscription

0.526

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.780

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.004

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.693

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.703

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.400

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.657

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.070

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.736

Nigericin50 uM Nigericinrespiration

-0.261

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.728

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.123

menadione6-10 ug/mL Menadionerespiration

-0.607

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.359

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.312

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.620

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.136

NRP_1Non-replicating persistence stage 1dosRassociated

-0.591

Amp0.2mg/mL AmpicillincellWall

-0.137

Cephalexin20-100 ug/mL CephalexincellWall

-0.289

Cerulenin0.32-5 ug/mL CerulenincellWall

0.960

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.008

EMB10-20 ug/mL EthambutolcellWall

-0.056

Eta12-40 ug/mL EthionamidecellWall

0.297

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.218

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.633

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.133

BZA0.12 mg/mL BenzamidearomaticAmides

-0.471

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.341

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.202

H2O24 mM hydrogen peroxideDNAdamaging

0.213

Levo10 ug/mL LevofloxacinDNAdamaging

-0.171

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.770

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.420

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.747

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.810

Antimycin12.5-50 ug/mL Antimycin A?

1.999

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.288

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.463

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.336

PA8240.2-2 ug/mL PA-824?

-0.581

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.310

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

2.367

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?